[ACRS] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -56.81%
YoY- -45.99%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 17,570 7,753 1,501 1,580 1,095 3,669 999 61.22%
PBT -1,858 -27,635 -22,804 -13,779 -19,177 -38,551 -24,764 -35.04%
Tax -367 5,656 2,003 -182 -32,181 -958 -1,830 -23.48%
NP -1,491 -33,291 -22,804 -13,173 -18,594 -38,551 -22,934 -36.57%
Tax Rate - - - - - - - -
Total Cost 19,061 41,044 24,305 14,753 19,689 42,220 23,933 -3.72%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -8.49 -429.40 -1,519.25 -833.73 -1,698.08 -1,050.72 -2,295.70 -60.65%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.02 -0.50 -0.37 -0.30 -0.45 -0.99 -0.74 -45.20%
EPS Diluted -0.02 -0.50 -0.37 -0.30 -0.45 -0.99 -0.74 -45.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.